Hacker News Reader

Note that this is a cooperation with Novo Nordisk, which is one of the "bad guys" in the insulin story.

So walmart convinced one of the "bad guys" to do a good. Still seems like a win to me.

Doesn't seem like a "good" as much as a "less bad".

Given the medical industry is more than okay with going Full Evil, I'm happy to see Walmart knocking them down a notch in evil.

If nothing else, this may cause something foreign to the medical industry- Competition.

I'm talking about the action itself, not the entity overall.

It’s a depressive win that masks all the other loses.